Back to search results

Music Therapy for Parkinson's Disease

This study is looking at how different types of music therapy affect people with Parkinson's disease (PD). Researchers want to see if listening to self-selected music (passive music therapy) or working with a licensed music therapist (active music therapy) can improve your ability to move and your motivation during exercise. They will measure how long it takes you to stand up from a chair and how far you can walk in six minutes. You may be able to join if you are between 50 and 89 years old, have a formal diagnosis of PD, and can walk without help. The study aims to enroll 28 participants, but its current recruitment status is unclear.

Study design
This is an interventional study with a planned enrollment of 28 participants. It uses a crossover design, meaning you will experience all study conditions.
What's involved
You will complete three separate experimental visits, each involving functional tests (sit-to-stand, 6-minute walk) and psychometric testing. These measurements will be taken at Week 1 and Week 2.
Compensation
Not stated in the trial record.
Follow-up
Your functional ability and motivation levels will be measured at Week 1 and Week 2.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07661524

Passive Versus Active Music Therapy Parkinson's Disease

Not Yet Recruiting
NAAges 50–89InterventionalTreatment
University of Alabama at Birmingham
~28 participants
Updated 2026-06-22 on ClinicalTrials.gov
What's tested:Passive music therapyActive music therapy

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Average time sit to stand
Measured over Week 1, Week 2
+2 more outcomes measured

Conditions

Parkinson Disease (PD)

Explore related trials

Parkinson Disease

NCT07661524

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • University of Alabama at Birmingham

    Birmingham, Alabamastudy coordinator listed

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Christopher G Ballmann, PhD · PRINCIPAL_INVESTIGATOR · University of Alabama at Birmingham

Who to contact

Christopher G Ballmann, PhD
[email protected]
205-975-0613
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Formal diagnosis of idiopathic PD
Hoen \& Yahr Stage \<III
Middle or old age onset of PD (at least 50 years of age)
The ability to ambulate without assistive devices
Stable medication regimen for four weeks prior to participation
No changes to treatment of PD in the last month.

Exclusion

Primary psychiatric disease (non-PD related)
Reports of falling in the last six weeks
Any reason a participant or their healthcare team believed their participation in the study could negatively impact their well-being.

What this trial measures

  • Average time sit to standWeek 1, Week 2

    Time to complete 5 sit to stand test

  • Total walking distance accumulated in 6 minutesWeek 1, Week 2

    Total distance in meters accumulated during a six minute walk test

  • Total motivation levelWeek 1, Week 2

    Motivation levels as assessed by a visual analog scale on 0 to 100 where 0 equals the absence of motivation and 100 indicates extremely motivated